Skip to main content
Erschienen in: Head and Neck Pathology 4/2021

26.05.2021 | Original Paper

Low Grade Papillary Sinonasal (Schneiderian) Carcinoma: A Series of Five Cases of a Unique Malignant Neoplasm with Comparison to Inverted Papilloma and Conventional Nonkeratinizing Squamous Cell Carcinoma

verfasst von: Mario W. Saab-Chalhoub, Xingyi Guo, Qiuying Shi, Rebecca D. Chernock, James S. Lewis Jr.

Erschienen in: Head and Neck Pathology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

There have been a few case reports and one small series of low grade papillary sinonasal (Schneiderian) carcinomas (LGPSC) which mimic papillomas but have overtly invasive growth and which occasionally metastasize. We describe the morphologic, clinical, immunohistochemical, and molecular features of five patients with LGPSC compared with eight cases each of inverted papilloma (IP) and conventional nonkeratinizing squamous cell carcinoma (SCC) with papillary growth. All LGPSC were nested with predominantly pushing invasion, no stromal reaction, and frequent surface papillary growth. All consisted of one cell type only, with polygonal cells with round nuclei, no (or limited) cytologic atypia, low mitotic activity, and prominent neutrophilic infiltrate. One patient had slightly more infiltrative bone invasion, another lymphovascular, perineural, and skeletal muscle invasion, and a third nodal metastasis after 17 years. By comparison, IPs had bland cytology, neutrophilic microabscesses, mixed immature squamous, goblet cell, and respiratory epithelium, and extremely low mitotic activity. Nonkeratinizing SCCs had basaloid-appearing cells with nuclear pleomorphism, brisk mitotic activity, and apoptosis. All LGPSC were p63 positive. Mitotic activity and Ki67 indices were significantly higher for LGPSCs than IPs and significantly lower than NKSCCs, while p53 immunohistochemistry in LGPSC was identical to nonkeratinizing SCC and higher than for IP. Sequencing showed all five tumors to harbor a MUC6 mutation, one tumor to harbor CDKN2A and PIK3R1 mutations, and one tumor to harbor a NOTCH1 mutation. All LGPSC lacked EGFR and KRAS mutations and lacked copy number variations of any main cancer genes. At a median follow up of 12 months, two LGPSC recurred locally, and one patient died after massive local recurrences and nodal metastases. LGPSC is a distinct, de novo sinonasal carcinoma that can be differentiated from papillomas by morphology and selected immunohistochemistry.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat El-Naggar A, Grandis JR, Chan JK, et al., editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC Press; 2017. El-Naggar A, Grandis JR, Chan JK, et al., editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC Press; 2017.
2.
Zurück zum Zitat Bishop JA, Brandwein-Gensler M, Nicolai P, et al. Nonkeratinizing squamous cell carcinoma. In: El-Naggar A, Grandis JR, Chan JK, et al., editors. WHO classification of head and neck tumors. Lyon: IARC Press; 2017. p. 15–7. Bishop JA, Brandwein-Gensler M, Nicolai P, et al. Nonkeratinizing squamous cell carcinoma. In: El-Naggar A, Grandis JR, Chan JK, et al., editors. WHO classification of head and neck tumors. Lyon: IARC Press; 2017. p. 15–7.
3.
Zurück zum Zitat Ansa B, Goodman M, Ward K, et al. Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009. Cancer. 2013;119:2602–10.CrossRef Ansa B, Goodman M, Ward K, et al. Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009. Cancer. 2013;119:2602–10.CrossRef
4.
Zurück zum Zitat Brown NA, Plouffe KR, Yilmaz O, et al. TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas. Mod Pathol. 2020 (online ahead of print). Brown NA, Plouffe KR, Yilmaz O, et al. TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas. Mod Pathol. 2020 (online ahead of print).
5.
Zurück zum Zitat Kaufman MR, Brandwein MS, Lawson W. Sinonasal papillomas: clinicopathologic review of 40 patients with inverted and oncocytic schneiderian papillomas. Laryngoscope. 2002;112:1372–7.CrossRef Kaufman MR, Brandwein MS, Lawson W. Sinonasal papillomas: clinicopathologic review of 40 patients with inverted and oncocytic schneiderian papillomas. Laryngoscope. 2002;112:1372–7.CrossRef
6.
Zurück zum Zitat Lawson W, Ho BT, Shaari CM, et al. Inverted papilloma: a report of 112 cases. Laryngoscope. 1995;105:282–8.CrossRef Lawson W, Ho BT, Shaari CM, et al. Inverted papilloma: a report of 112 cases. Laryngoscope. 1995;105:282–8.CrossRef
7.
Zurück zum Zitat Lewis JS Jr, Chernock RD, Haynes W, et al. Low-grade papillary schneiderian carcinoma, a unique and deceptively bland malignant neoplasm: report of a case. Am J Surg Pathol. 2015;39:714–21.CrossRef Lewis JS Jr, Chernock RD, Haynes W, et al. Low-grade papillary schneiderian carcinoma, a unique and deceptively bland malignant neoplasm: report of a case. Am J Surg Pathol. 2015;39:714–21.CrossRef
8.
Zurück zum Zitat Lewis JS Jr, Beadle B, Bishop JA, et al. Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists. Arch Pathol Lab Med. 2018;142:559–97.CrossRef Lewis JS Jr, Beadle B, Bishop JA, et al. Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists. Arch Pathol Lab Med. 2018;142:559–97.CrossRef
9.
Zurück zum Zitat Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.CrossRef Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.CrossRef
10.
Zurück zum Zitat Chen Z, Wen W, Beeghly-Fadiel A, et al. Identifying putative susceptibility genes and evaluating their associations with somatic mutations in human cancers. Am J Hum Genet. 2019;105:477–92.CrossRef Chen Z, Wen W, Beeghly-Fadiel A, et al. Identifying putative susceptibility genes and evaluating their associations with somatic mutations in human cancers. Am J Hum Genet. 2019;105:477–92.CrossRef
11.
Zurück zum Zitat McCluggage WG, Soslow RA, Gilks CB. Patterns of p53 immunoreactivity in endometrial carcinomas: “all or nothing” staining is of importance. Histopathology. 2011;59:786–8.CrossRef McCluggage WG, Soslow RA, Gilks CB. Patterns of p53 immunoreactivity in endometrial carcinomas: “all or nothing” staining is of importance. Histopathology. 2011;59:786–8.CrossRef
12.
Zurück zum Zitat Yemelyanova A, Vang R, Kshirsagar M, et al. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol. 2011;24:1248–53.CrossRef Yemelyanova A, Vang R, Kshirsagar M, et al. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol. 2011;24:1248–53.CrossRef
13.
Zurück zum Zitat McNamara MG, Jacobs T, Lamarca A, et al. Impact of high tumor mutational burden in solid tumors and challenges for biomarker application. Cancer Treat Rev. 2020;89:102084.CrossRef McNamara MG, Jacobs T, Lamarca A, et al. Impact of high tumor mutational burden in solid tumors and challenges for biomarker application. Cancer Treat Rev. 2020;89:102084.CrossRef
14.
Zurück zum Zitat Hatakeyama K, Nagashima T, Ohshima K, et al. Characterization of tumors with ultralow tumor mutational burden in Japanese cancer patients. Cancer Sci. 2020; 111: 3893–3901.CrossRef Hatakeyama K, Nagashima T, Ohshima K, et al. Characterization of tumors with ultralow tumor mutational burden in Japanese cancer patients. Cancer Sci. 2020; 111: 3893–3901.CrossRef
15.
Zurück zum Zitat Fromer M, Moran JL, Chambert K, et al. Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. Am J Hum Genet. 2012;91:597–607.CrossRef Fromer M, Moran JL, Chambert K, et al. Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. Am J Hum Genet. 2012;91:597–607.CrossRef
16.
Zurück zum Zitat Bishop JA, Gagan J, Paterson C, et al. Nonkeratinizing squamous cell carcinoma of the sinonasal tract with DEK-AFF2: further solidifying an emerging entity. Am J Surg Pathol. 2020;45:718–20.CrossRef Bishop JA, Gagan J, Paterson C, et al. Nonkeratinizing squamous cell carcinoma of the sinonasal tract with DEK-AFF2: further solidifying an emerging entity. Am J Surg Pathol. 2020;45:718–20.CrossRef
17.
Zurück zum Zitat Todorovic E, Truong T, Eskander A, et al. Middle ear and temporal bone nonkeratinizing squamous cell carcinomas with DEK-AFF2 fusion: an emerging entity. Am J Surg Pathol. 2020;44:1244–50.CrossRef Todorovic E, Truong T, Eskander A, et al. Middle ear and temporal bone nonkeratinizing squamous cell carcinomas with DEK-AFF2 fusion: an emerging entity. Am J Surg Pathol. 2020;44:1244–50.CrossRef
18.
Zurück zum Zitat Brown CS, Abi Hachem R, Pendse A, et al. Low-grade papillary schneiderian carcinoma of the sinonasal cavity and temporal bone. Ann Otol Rhinol Laryngol. 2018;127:974–7.CrossRef Brown CS, Abi Hachem R, Pendse A, et al. Low-grade papillary schneiderian carcinoma of the sinonasal cavity and temporal bone. Ann Otol Rhinol Laryngol. 2018;127:974–7.CrossRef
19.
Zurück zum Zitat Carnevale S, Ferrario G, Sovardi F, et al. Low-grade papillary schneiderian carcinoma: report of a case with molecular characterization. Head Neck Pathol. 2020;14:799–802.CrossRef Carnevale S, Ferrario G, Sovardi F, et al. Low-grade papillary schneiderian carcinoma: report of a case with molecular characterization. Head Neck Pathol. 2020;14:799–802.CrossRef
20.
Zurück zum Zitat Jeong HJ, Roh J, Lee BJ, et al. Low-grade papillary schneiderian carcinoma: a case report. Head Neck Pathol. 2018;12:131–5.CrossRef Jeong HJ, Roh J, Lee BJ, et al. Low-grade papillary schneiderian carcinoma: a case report. Head Neck Pathol. 2018;12:131–5.CrossRef
21.
Zurück zum Zitat Williamson A, Sharma R, Cooper L, et al. Low-grade papillary schneiderian carcinoma; rare or under-recognised? Otolaryngol Case Rep. 2019;11:100107.CrossRef Williamson A, Sharma R, Cooper L, et al. Low-grade papillary schneiderian carcinoma; rare or under-recognised? Otolaryngol Case Rep. 2019;11:100107.CrossRef
22.
Zurück zum Zitat Zhai C, Wang H, Li S, et al. Clinicopathological analysis of low-grade papillary Schneiderian carcinoma: report of five new cases and review of the literature. Histopathology. 2021 (online ahead of print). Zhai C, Wang H, Li S, et al. Clinicopathological analysis of low-grade papillary Schneiderian carcinoma: report of five new cases and review of the literature. Histopathology. 2021 (online ahead of print).
23.
Zurück zum Zitat King RJ, Yu F, Singh PK. Genomic alterations in mucins across cancers. Oncotarget. 2017;8:67152–68.CrossRef King RJ, Yu F, Singh PK. Genomic alterations in mucins across cancers. Oncotarget. 2017;8:67152–68.CrossRef
24.
Zurück zum Zitat Mukhopadhyay P, Chakraborty S, Ponnusamy MP, et al. Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy. Biochim Biophys Acta. 2011;1815:224–40.PubMedPubMedCentral Mukhopadhyay P, Chakraborty S, Ponnusamy MP, et al. Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy. Biochim Biophys Acta. 2011;1815:224–40.PubMedPubMedCentral
25.
Zurück zum Zitat Ali MS, Pearson JP. Upper airway mucin gene expression: a review. Laryngoscope. 2007;117:932–8.CrossRef Ali MS, Pearson JP. Upper airway mucin gene expression: a review. Laryngoscope. 2007;117:932–8.CrossRef
26.
Zurück zum Zitat Mountzios G, Rampias T, Psyrri A. The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact. Ann Oncol. 2014;25:1889–900.CrossRef Mountzios G, Rampias T, Psyrri A. The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact. Ann Oncol. 2014;25:1889–900.CrossRef
27.
Zurück zum Zitat Perez Sayans M, Chamorro Petronacci CM, Lorenzo Pouso AI, et al. Comprehensive genomic review of TCGA head and neck squamous cell carcinomas (HNSCC). J Clin Med. 2019;8:1896.CrossRef Perez Sayans M, Chamorro Petronacci CM, Lorenzo Pouso AI, et al. Comprehensive genomic review of TCGA head and neck squamous cell carcinomas (HNSCC). J Clin Med. 2019;8:1896.CrossRef
28.
Zurück zum Zitat Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333:1157–60.CrossRef Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333:1157–60.CrossRef
29.
Zurück zum Zitat Udager AM, McHugh JB, Goudsmit CM, et al. Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas. Ann Oncol. 2018;29:466–71.CrossRef Udager AM, McHugh JB, Goudsmit CM, et al. Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas. Ann Oncol. 2018;29:466–71.CrossRef
30.
Zurück zum Zitat Udager AM, Rolland DCM, McHugh JB, et al. High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma. Can Res. 2015;75:2600–6.CrossRef Udager AM, Rolland DCM, McHugh JB, et al. High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma. Can Res. 2015;75:2600–6.CrossRef
Metadaten
Titel
Low Grade Papillary Sinonasal (Schneiderian) Carcinoma: A Series of Five Cases of a Unique Malignant Neoplasm with Comparison to Inverted Papilloma and Conventional Nonkeratinizing Squamous Cell Carcinoma
verfasst von
Mario W. Saab-Chalhoub
Xingyi Guo
Qiuying Shi
Rebecca D. Chernock
James S. Lewis Jr.
Publikationsdatum
26.05.2021
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 4/2021
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-021-01335-3

Weitere Artikel der Ausgabe 4/2021

Head and Neck Pathology 4/2021 Zur Ausgabe

Sine qua non Radiology-Pathology

Sine Qua Non: Dentigerous Cyst

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …